>>Also, the government has no business sticking its nose into how GILD prices its drugs
The government will likely end up paying for the majority of patients with HCV, so at least from that perspective it's not exactly none of their business.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.